A Study to Investigate the Antitumor Activity, Safety, Tolerability, and Pharmacokinetics of BGB-A445 in Combination With Tislelizumab in Participants With Select Advanced Solid Tumors.

Beijing Cancer Hospital, Beijing

Liaoning Cancer Hospital and Institute, Shenyang

The First Hospital of Jilin University, Changchun

Nanjing Drum Tower Hospital,the Affiliated Hospital of Nanjing University Medical School, Nanjing

Shandong Cancer Hospital, Jinan

Jining No Peoples Hospital West Branch, Jining

Tianjin Medical University Cancer Institute and Hospital, Tianjin

The First Affiliated Hospital of Wenzhou Medical University, Wenzhou

Fujian Cancer Hospital, Fuzhou

The Second Xiangya Hospital of Central South University, Changsha

Tongji Hospital of Tongji Medical College Huazhong University of Science and Technology, Wuhan

The First Affiliated Hospital of Zhengzhou University, Zhengzhou

Zhujiang Hospital of Southern Medical University, Guangzhou

Sun Yat Sen University Cancer Center, Guangzhou

The Tumor Hospital Affiliated to Guangxi Medical University, Nanning

West China Hospital, Sichuan University, Chengdu

The Second Hospital and Clinical Medical School, Lanzhou University, Lanzhou

Shanxi Provincial Cancer Hospital, Taiyuan